Riskpilot← Back to searchSign inGet full accessBlodtrycksdoktorn AB
ABActiveOrg 5591145023Bredbandet 1 VarvsholmenMedical specialists activities · NACE 8622Est. 201741 employees
Revenue 2024
SEK 67,8M
+37% vs 2023
EBITDA margin
-24.2%
+4% vs 2023
Equity ratio
63.2%
Financial strength
Net profit 2024
SEK -27M
+1% vs 2023
| Revenue | SEK 67,8M | +37% |
| EBITDA | SEK -16,4M | +4% |
| Net profit | SEK -27M | +1% |
| Total assets | SEK 58,7M | +16% |
| Equity | SEK 37,1M | +54% |
| Employees | 41 | — |
Legal name
Blodtrycksdoktorn AB
Org number
5591145023
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 juni 2017
Share capital
SEK 1 069 870
Employees
41 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med Wohlin, Carl Jonas Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva sjukvård och utveckling av digitala lösningar för kroniska sjukdomar samt därmed förenlig verksamhet.
Address
Bredbandet 1 Varvsholmen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 7 | 952 | 12 201 | 17 519 | 38 779 | 49 416 | 67 821 |
| Staff expenses | — | — | — | — | — | — | — | −46 344 |
| EBITDA | −2 121 | −7 451 | −12 842 | −13 384 | −20 970 | −39 923 | −17 095 | −16 383 |
| Depreciation & amort. | −0 | −21 | −1 423 | −3 921 | −5 704 | −7 696 | −9 922 | −10 509 |
| EBIT | −2 121 | −7 472 | −14 265 | −17 305 | −26 674 | −47 619 | −27 017 | −26 893 |
| Net financials | — | −2 | −449 | −518 | −884 | −552 | −344 | −111 |
| Profit before tax | −2 121 | −7 474 | −14 714 | −17 823 | −27 558 | −48 171 | −27 361 | −27 003 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | 6 | — |
| Net profit | −2 121 | −7 474 | −14 714 | −17 823 | −27 558 | −48 171 | −27 355 | −27 003 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 1 597 | 8 772 | 24 655 | 31 453 | 66 247 | 77 155 | 50 636 | 58 714 |
| Equity | 99 | 653 | 16 804 | −726 | 39 953 | 51 407 | 24 052 | 37 122 |
| Long-term debt | 0 | 0 | 3 063 | 5 587 | 3 965 | 7 341 | 2 468 | 6 955 |
| Short-term debt | 1 498 | 8 119 | 4 789 | 26 592 | 22 329 | 18 407 | 24 117 | 14 637 |
| Total debt | 1 498 | 8 119 | 7 852 | 32 179 | 26 294 | 25 748 | 26 585 | 21 592 |
EBITDA margin
-24.2%
This company
15.8%
Market median
-253% vs market
20172024
Equity ratio
63.2%
This company
38.2%
Market median
+65% vs market
20172024
Return on equity
-72.7%
This company
18.4%
Market median
-495% vs market
20172024
Net profit margin
-39.8%
This company
8.1%
Market median
-591% vs market
20172024
Asset turnover
1.16×
This company
1.12×
Market median
+4% vs market
20172024
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20172024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-06-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JA | Audit | 2022 | — | — |
BA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
MH | Audit | 2020 | — | — |
CJ Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
JR Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Blodtrycksdoktorn AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Andreas Håkan Kling | Audit | 0 companies |
| Björn Anders Pontus Bodelsson | Chief Executive Officer | 0 companies |
| Martin Henrik Carlsson | Audit | 0 companies |
| Carl Jonas Wohlin | Chief Executive Officer | 0 companies |
| John Robert Nyholm | Chief Auditor | 0 companies |
| Carl Christian Jansson | Chairman | 0 companies |
| Peter Sven Enberg | Chairman | 0 companies |
| Lars Magnus Nyhlén | Board of Directors | 0 companies |
| Mats Stefan Langåker | Board of Directors | 0 companies |
| Lars Victor Harald Steien | Board of Directors | 0 companies |
| Curt Henrik Ulfsson Norström | Board of Directors | 0 companies |
| Christian Jansson | Board of Directors | 0 companies |